WallStreetZenWallStreetZen

NASDAQ: KTTA
Pasithea Therapeutics Corp Stock Ownership - Who owns Pasithea Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pasithea Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Simon DumesnilDirector2025-11-2833,333$0.75
$25.00kBuy
Emer LeahyDirector2025-11-2833,333$0.75
$25.00kBuy
Tiago MarquesChief Executive Officer2025-11-2833,333$0.75
$25.00kBuy
Daniel H. SchneidermanChief Financial Officer2025-11-2826,667$0.75
$20.00kBuy
Lawrence SteinmanDirector2025-11-28133,333$0.75
$100.00kBuy
Tiago MarquesChief Executive Officer2025-05-12960$0.83
$792.00Sell

1 of 1

KTTA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KTTA insiders and whales buy or sell their stock.

KTTA Shareholders

What type of owners hold Pasithea Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pd Joint Holdings LLC Series 2016a35.05%2,608,696$3.10MInsider
Eric Shahinian24.03%1,788,415$2.13MInsider
Israel Maxx Abramowitz14.13%1,051,575$1.25MInsider
Avi Geller13.90%1,034,702$1.23MInsider
Eric Lazer12.13%902,600$1.07MInsider
Dean Lazer12.13%902,600$1.07MInsider
Yassine Bendiabdallah4.03%300,000$357.00kInsider
Advisorshares Investments LLC3.46%257,696$306.66kInstitution
David Delaney3.06%227,521$270.75kInsider
Lawrence Steinman2.68%199,691$237.63kInsider

1 of 3

KTTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KTTA6.25%93.75%Net BuyingNet Buying
APVO12.10%87.90%Net BuyingNet Buying
TOVX1.30%0.74%
GTBP3.52%11.34%
ERNA0.38%99.62%Net Buying
View Top Biotech Stocks

Pasithea Therapeutics Stock Ownership FAQ

Who owns Pasithea Therapeutics?

Pasithea Therapeutics (NASDAQ: KTTA) is owned by 8.23% institutional shareholders, 123.44% Pasithea Therapeutics insiders, and 0.00% retail investors. Pd Joint Holdings LLC Series 2016a is the largest individual Pasithea Therapeutics shareholder, owning 2.61M shares representing 35.05% of the company. Pd Joint Holdings LLC Series 2016a's Pasithea Therapeutics shares are currently valued at $3.10M.

If you're new to stock investing, here's how to buy Pasithea Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.